What drugs does NOVIMMUNE S.A. make?

NOVIMMUNE S.A. has 1 FDA-approved drugs.

What therapeutic areas does NOVIMMUNE S.A. focus on?

NOVIMMUNE S.A. focuses primarily on Immunology and Oncology.

Data updated: Mar 10, 2026

ImmunologyOncology

Biotech

NOVIMMUNE S.A. is a biotechnology company focused on Immunology, Oncology.

2018

Since

Drugs

Trials

Approved (2yr)

No active drugs

SEC Filings ProEarly access

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 80%

1 drugs Phase 2: 1

Oncology 20%

0 drugs Phase 1: 2